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Is the Fagerström Test for 
Nicotine Dependence a 
good instrument to assess 
tobacco  use in patients with 
schizophrenia?
O Teste de Fagerström para Dependência 
de Nicotina é um bom instrumento para 
avaliar o uso de tabaco em pacientes com 
esquizofrenia?
Dear Editor,
We have read with great interest the article by Chaves and 
Shirakawa,1 in which the authors confirmed previous observations 
that patients with schizophrenia smoke in a higher rate as compared 
to the general population. They also observed that the patients 
were considered as heavy smokers according to the Fagerström 
Tolerance Questionnaire (FTQ).
Although the FTQ is considered to be adequate to assess nicotine 
dependence due to its extensive use, it suffers from significant 
psychometric shortcomings, such as low internal consistency and 
poor criterion validity.2 In order to address these problems, the 
Fagerström Test for Nicotine Dependence (FTND) was developed. 
The modifications of the FTQ consisted in the elimination of two 
items (“nicotine content of cigarette”; “frequency of inhalation”) 
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and in the expansion of the scoring format for two items (“time to 
first cigarette”; “number of cigarettes smoked per day”), resulting 
in a six-item questionnaire that provides a 0-10 score. The results 
from both the original study and subsequent research indicate that 
the FTND has satisfactory psychometric qualities due to its greater 
internal consistency and to the fact that it has a single factor.2 
However, no studies to date have evaluated the psychometric 
properties of the translated Portuguese version of this instrument. 
We have recently3 examined this issue using the Brazilian version 
of the FTND in three different samples of smokers: university 
students (n = 61); patients of a Psychosocial Care Center for 
Alcohol and Drug Users (PCC-AD; n = 30) and patients treated 
at an Emergency Unit and at the PCC-AD (n = 271). The FTND 
showed high reliability levels, with correlation coefficients of 0.92 
for test-retest and 0.99 for inter-rater reliability. At the cut-off score 
of four, the instrument presented a sensitivity of 0.80, specificity 
of 0.74, positive predictive value of 0.95, and negative predictive 
value of 0.30. The evaluation of the internal consistency yielded 
a Cronbach’s alpha coefficient of 0.83. An Exploratory Factorial 
Analysis found two factors in the FTND (‘Smoking Pattern’ and 
‘Morning Smoking’ factors), attested by a Confirmatory Factor 
Analysis. Thus, the results obtained in our study confirm the 
efficiency of the Brazilian version of the FTND.
Nevertheless, few studies (none in the Brazilian context) have 
examined the psychometric properties of the FTND in smokers with 
schizophrenia. This would be particularly important since some 
questions have been raised about the applicability of the FTND to 
this population. The patients’ smoking habits are usually controlled 
by others and there seem to exist differences between the smoking 
patterns, living arrangements, and daily routines of patients and 
healthy individuals.4 These factors are believed to produce an 
underestimation of nicotine dependence in schizophrenia, which 
may have a negative impact in the dosage of the nicotine replacement 
treatment if the FTND scores are used to guide it.4 For instance, 
Weinberger et al. studied the reliability of the FTND in smokers with 
schizophrenia and observed that the test-retest correlations were 
lower for patients than for controls (0.65 versus 0.82).5 Moreover, 
when the test was administered to schizophrenia patients, lower 
internal consistency (Cronbach’s alpha) and a non-conventional 
factorial structure were found.4 To date, as far as we know, there is 
no validity study of the FTND in patients with schizophrenia.2
Therefore, despite its wide use in research and clinical practice, 
the FTND still requires further psychometric investigation 
including patients with schizophrenia. In particular, studies 
evaluating its validity are necessary and opportune in order to 
provide the basis for the definition of specific cut-off points for 
this psychiatric population. 
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